跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 114,599 条关于
“Charcot Marie Tooth disease, Type 2C”
全部
114,599
临床试验
89,378
药物
1,989
机构
218
资讯
23,014
去年
Actio Biosciences Raises $66M Series B to Advance Rare Disease Programs Targeting Ion Channel Disorders
去年
Actio Biosciences Advances Precision Medicine Platform for Rare and Common Diseases
去年
First Patient Dosed in Phase 1 Trial of ABS-0871 for Charcot-Marie-Tooth Disease 2C Treatment
去年
Advancements in Clinical Outcome Assessments and Biomarkers Pave the Way for CMT Treatment
去年
Augustine Therapeutics Secures €78 Million to Advance HDAC6 Inhibitor for Charcot-Marie-Tooth Disease
11个月前
ReviR Therapeutics Secures FDA Orphan Drug Designation for RTX-117 in Charcot-Marie-Tooth Disease
去年
NMD Pharma's NMD670 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease
7个月前
NMD Pharma's Ignaseclant Shows Promise in Phase 2a Trial for Charcot-Marie-Tooth Disease
23天前
ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease
2年前
ENCell's Mesenchymal Stem Cell Therapy Shows Promise in First-in-Human Trial for Charcot-Marie-Tooth Disease
第 1 页，共 2302 页
上一页
下一页
